Related Experiment Videos
Effect of prolonged dexamethasone on oxygen-dependency in infants with chronic lung disease
V Zanardo1, D Trevisanuto, E Vanin
1Department of Pediatrics, University of Padua, Italy.
Insights
Prolonged dexamethasone therapy effectively reduced oxygen dependency in premature infants with bronchopulmonary dysplasia. Most infants were weaned from oxygen within 42 days, showing significant improvement.
Area of Science:
- Neonatology
- Pediatric Pulmonology
- Pharmacology
Background:
- Bronchopulmonary dysplasia (BPD) is a chronic lung disease in premature infants.
- Oxygen dependency is a significant clinical challenge in managing BPD.
- Prolonged corticosteroid therapy is explored for its effects on respiratory outcomes.
Purpose of the Study:
- To evaluate the impact of prolonged dexamethasone therapy on oxygen dependency in premature infants with BPD.
- To assess the efficacy of dexamethasone in facilitating oxygen weaning in this vulnerable population.
Main Methods:
- A cohort of 27 premature infants (birth weight < 1500g, gestational age < 32 weeks) with persistent oxygen dependency post-respirator were treated.
- Infants received prolonged dexamethasone therapy over a 42-day period.
- Fraction of inspired oxygen (FiO2) levels were monitored to assess oxygen requirements before, during, and after treatment.
Main Results:
- Twenty-five of 27 infants (92.6%) were successfully weaned from supplemental oxygen during the 42-day treatment.
- The mean duration of oxygen supplementation post-treatment was 16 +/- 4 days.
- A statistically significant, time-dependent reduction in FiO2 was observed, following an exponential decay pattern.
Conclusions:
- Prolonged dexamethasone therapy is effective in reducing oxygen dependency in premature infants with bronchopulmonary dysplasia.
- The treatment facilitates oxygen weaning and demonstrates a predictable decline in oxygen requirements over time.
- Individualized treatment duration can be estimated based on pre-treatment oxygen severity.
Abstract:
To determine the effect of prolonged dexamethasone therapy on oxygen-dependency clinical phase of prematures with bronchopulmonary dysplasia, we examined a consecutive group of 27 infants (birth weight, < 1500 g and gestational age, < 32 weeks), who remained with a static or deteriorating oxygen-dependency after weaning from the respirator [pre-treatment FiO2, mean +/- SEM over three days (31 +/- 2)%, range (27-73)%]. Twenty five out of 27 infants were weaned from supplemental oxygen during the 42-day steroid treatment period, with a mean (+/- SEM) duration of oxygen supplementation of 16 +/- 4 days. The distribution of the ratios of successive post-treatment FiO2 values with respect to pre-treatment FiO2 shows, on average, a progressive reduction with time. The percentage of the FiO2 decrease is statistically significant at a level of 2 and 3 SD after 3 days and 7 days, respectively and the average FiO2 fall, as function of time, follows an exponential law. It follows that the time spent in oxygen for a single patient may be determined, accounting for the individual severity of pre-treatment FiO2.